MedTrace Logo

Feasibility of OmnEcoil System for Integrated Endorectal MRI and Transrectal MRI-Targeted Biopsy of the Prostate

NCT05362032 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2026-05-04

No results posted yet for this study

Summary

This clinical trial tests whether it is feasible to use the OmnEcoil system for transrectal magnetic resonance imaging (MRI) to visualize and biopsy suspicious lesions in the prostate. The OmnEcoil device combines an endorectal coil (a type of wire placed within the rectum during diagnostic endorectal MRI to take better images of the prostate) with an endorectal probe. The OmnEcoil system is designed to allow for MRI to be used at the same time to image the prostate and aid in the biopsy of the suspected prostate cancer. Usually, these are performed as two separate events at two separate times.

Conditions

  • Prostate Carcinoma

Interventions

DEVICE

Biopsy

Undergo transrectal MRI-targeted biopsy

PROCEDURE

Endorectal Magnetic Resonance Imaging

Endorectal MRI

Sponsors & Collaborators

  • Oregon Health and Science University

    collaborator OTHER

  • U.S. National Science Foundation

    collaborator FED

  • OHSU Knight Cancer Institute

    lead OTHER

Principal Investigators

  • Fergus V Coakley · OHSU Knight Cancer Institute

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-08
Primary Completion
2027-06-30
Completion
2028-07-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05362032 on ClinicalTrials.gov